Bid Publish Date
13-Aug-2026, 9:52 pm
Bid End Date
29-Aug-2026, 9:00 am
EMD
₹40,700
Location
Progress
The Municipal Corporation Of Delhi (MCD) invites bids for an injection pharmaceutical procurement package located in West Delhi (110008). The initiative covers a broad range of injectable drugs and related infusions, including antiarrhythmics, sedatives, antiemetics, antibiotics, vitamins, and saline infusions, with a total of 38 items listed in the BOQ. The estimated value is not disclosed, but the tender specifies an EMD of ₹40,700 and targets suppliers capable of handling hospital-grade supply to Mata Gujri Hospital, Tilak Nagar, New Delhi. A key differentiator is the on-site delivery and commissioning at a municipal hospital address, with flexible quantity options up to 25% per order and during contract currency at contracted rates. The tender emphasizes compliance with safety, insurance, and EHDV worksite norms and requires formal turnover validation and financial health documentation. Unique aspects include on-premise delivery to a government hospital and a framework allowing option-based quantity adjustments during performance.
EMD = ₹40,700; DD acceptable with hardcopy delivery within 5 days
Delivery to Mata Gujri Hospital; on-site installation where applicable
25% quantity variation allowed during contract; extended delivery timeline rules
EMD paid via DD to Commissioner MCD; payment terms aligned with government procurement; delivery milestones tied to original/order dates
Delivery starts from last date of original delivery order; option clause may extend time; minimum 30-day extension for increased quantities
Penalties not explicitly listed; compliance with delivery and safety norms implied; non-compliance may lead to rejection or contract termination
Minimum turnover details as per bid document (3-year average)
Not in liquidation or under receivership
Authorized to supply pharmaceutical injectables with OEM authorizations
Quantity
49240
Category
Inj. Iron Sucrose
Bid Type
Two Packet Bid
Bid Validity
180 (Days)
Bid Type
Service
Evaluation
Total value wise evaluation
Inspection Required
No
RA Qualification Rule
50% Lowest Priced Technically Qualified Bidders
Tech Clarification Time
2 Days
EMD Required
Yes
MII Purchase Preference
No
MSE Purchase Preference
No
MSE Exemption/Relaxation
No
Startup Exemption/Relaxation
No
Bid Splitting Applied
No
Past Performance
10 %
Arbitration Clause
No
Mediation Clause
No
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
Yes
Item Category
Inj. Glycopyrrolate , Inj. Neostigmine , Inj. Phenobarbitone , Inj. Soda Bicarbonate , Inj. Phenytoin Sodium , Inj. Potassium Chloride , Inj. Diltiazem , Inj. Diazepam , Inj. Levetiracetam , Inj. Lorazepam , Inj. Lidocaine , Inj. MVI - Multivitamin Infusion , Inj. Nitroglycerine , Inj. Prochlorperazine , Inj. Triamcinolone , Inj. Mitomycin , Inj. Atropine , Inj. Clonidine , Inj. Ketamine , Inj. Loxicard 2 percent , Inj. Lignocaine EADR , Inj. Loxicard 4 percent , Inj. Lignocaine 2 percent , Inj. Myopyrolate , Inj. Pilocarpine , Inj. Hyaluronidase , Infusion Normal Saline 3 Percent , Inj. Tetanus Toxoid 0.5 ml , Inj. Etophylline plus Theophylline , Inj. Aspart Insulin , Inj. Iron Sucrose , Inj. Ethamsylate , Inj. Human Actrapid -Regular Insulin , Inj. Heparin , Inj. Ondansetron , Inj. Ranitidine , Inj. Dexamethasone
Advisory Bank
State Bank of India
Payment Timelines
Payments shall be made to the Seller within 45 days of issue of consignee receipt-cum-acceptance certificate (CRAC) and on-line submission of bills (This is in supersession of 10 days time as provided in clause 12 of GeM GTC)
Max Delivery Days
45
Delivery Locations
1
Delivery Cities
West
Delivery Pincodes
110018
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| Rajneesh Mohan Siwan | 110018,11 BLOCK TILAK NAGAR, NEW DELHI 110018 | West | Delhi | 110018 | 1400 | 45 | - |
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Inj. Glycopyrrolate
Inj. Glycopyrrolate
Inj. Neostigmine
Inj. Neostigmine
Inj. Phenobarbitone
Inj. Phenobarbitone
Inj. Soda Bicarbonate
Inj. Soda Bicarbonate
Inj. Phenytoin Sodium
Inj. Phenytoin Sodium
Inj. Potassium Chloride
Inj. Potassium Chloride
Inj. Diltiazem
Inj. Diltiazem
Inj. Diazepam
Inj. Diazepam
Inj. Levetiracetam
Inj. Levetiracetam
Inj. Lorazepam
Inj. Lorazepam
Inj. Lidocaine
Inj. Lidocaine
Inj. MVI -Multivitamin Infusion
Inj. MVI -Multivitamin Infusion
Inj. Nitroglycerine
Inj. Nitroglycerine
Inj. Prochlorperazine
Inj. Prochlorperazine
Inj. Triamcinolone
Inj. Triamcinolone
Inj. Mitomycin
Inj. Mitomycin
Inj. Atropine
Inj. Atropine
Inj. Clonidine
Inj. Clonidine
Inj. Ketamine
Inj. Ketamine
Inj. Loxicard 2 percent
Inj. Loxicard 2 percent
Inj. Lignocaine EADR
Inj. Lignocaine EADR
Inj. Loxicard 4 percent
Inj. Loxicard 4 percent
Inj. Lignocaine 2 percent
Inj. Lignocaine 2 percent
Inj. Myopyrolate
Inj. Myopyrolate
Inj. Neostigmine
Inj. Neostigmine
Inj. Pilocarpine
Inj. Pilocarpine
Inj. Hyaluronidase
Inj. Hyaluronidase
Infusion Normal Saline 3 Percent
Infusion Normal Saline 3 Percent
Inj. Tetanus Toxoid 0.5 ml
Inj. Tetanus Toxoid 0.5 ml
Inj. Etophylline plus Theophylline
Inj. Etophylline plus Theophylline
Inj. Aspart Insulin
Inj. Aspart Insulin
Inj. Iron Sucrose
Inj. Iron Sucrose
Inj. Ethamsylate
Inj. Ethamsylate
Inj. Human Actrapid -Regular Insulin
Inj. Human Actrapid -Regular Insulin
Inj. Heparin
Inj. Heparin
Inj. Ondansetron
Inj. Ondansetron
Inj. Ranitidine
Inj. Ranitidine
Inj. Dexamethasone
Inj. Dexamethasone
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Inj. Glycopyrrolate | Inj. Glycopyrrolate | 1,400 | ampoules or vials | cmomgh | 45 | |
| 2 | Inj. Neostigmine | Inj. Neostigmine | 1,200 | ampoules or vials | cmomgh | 45 | |
| 3 | Inj. Phenobarbitone | Inj. Phenobarbitone | 200 | ampoules or vials | cmomgh | 45 | |
| 4 | Inj. Soda Bicarbonate | Inj. Soda Bicarbonate | 100 | ampoules or vials | cmomgh | 45 | |
| 5 | Inj. Phenytoin Sodium | Inj. Phenytoin Sodium | 100 | ampoules or vials | cmomgh | 45 | |
| 6 | Inj. Potassium Chloride | Inj. Potassium Chloride | 100 | ampoules or vials | cmomgh | 45 | |
| 7 | Inj. Diltiazem | Inj. Diltiazem | 20 | ampoules or vials | cmomgh | 45 | |
| 8 | Inj. Diazepam | Inj. Diazepam | 10 | ampoules or vials | cmomgh | 45 | |
| 9 | Inj. Levetiracetam | Inj. Levetiracetam | 200 | ampoules or vials | cmomgh | 45 | |
| 10 | Inj. Lorazepam | Inj. Lorazepam | 10 | ampoules or vials | cmomgh | 45 | |
| 11 | Inj. Lidocaine | Inj. Lidocaine | 60 | ampoules or vials | cmomgh | 45 | |
| 12 | Inj. MVI -Multivitamin Infusion | Inj. MVI -Multivitamin Infusion | 100 | ampoules or vials | cmomgh | 45 | |
| 13 | Inj. Nitroglycerine | Inj. Nitroglycerine | 20 | ampoules or vials | cmomgh | 45 | |
| 14 | Inj. Prochlorperazine | Inj. Prochlorperazine | 1,000 | ampoules or vials | cmomgh | 45 | |
| 15 | Inj. Triamcinolone | Inj. Triamcinolone | 40 | ampoules or vials | cmomgh | 45 | |
| 16 | Inj. Mitomycin | Inj. Mitomycin | 10 | ampoules or vials | cmomgh | 45 | |
| 17 | Inj. Atropine | Inj. Atropine | 250 | ampoules or vials | cmomgh | 45 | |
| 18 | Inj. Clonidine | Inj. Clonidine | 20 | ampoules or vials | cmomgh | 45 | |
| 19 | Inj. Ketamine | Inj. Ketamine | 20 | ampoules or vials | cmomgh | 45 | |
| 20 | Inj. Loxicard 2 percent | Inj. Loxicard 2 percent | 30 | ampoules or vials | cmomgh | 45 | |
| 21 | Inj. Lignocaine EADR | Inj. Lignocaine EADR | 50 | ampoules or vials | cmomgh | 45 | |
| 22 | Inj. Loxicard 4 percent | Inj. Loxicard 4 percent | 50 | ampoules or vials | cmomgh | 45 | |
| 23 | Inj. Lignocaine 2 percent | Inj. Lignocaine 2 percent | 60 | ampoules or vials | cmomgh | 45 | |
| 24 | Inj. Myopyrolate | Inj. Myopyrolate | 200 | ampoules or vials | cmomgh | 45 | |
| 25 | Inj. Neostigmine | Inj. Neostigmine | 300 | ampoules or vials | cmomgh | 45 | |
| 26 | Inj. Pilocarpine | Inj. Pilocarpine | 100 | ampoules or vials | cmomgh | 45 | |
| 27 | Inj. Hyaluronidase | Inj. Hyaluronidase | 50 | ampoules or vials | cmomgh | 45 | |
| 28 | Infusion Normal Saline 3 Percent | Infusion Normal Saline 3 Percent | 400 | ampoules or vials | cmomgh | 45 | |
| 29 | Inj. Tetanus Toxoid 0.5 ml | Inj. Tetanus Toxoid 0.5 ml | 5,000 | ampoules or vials | cmomgh | 45 | |
| 30 | Inj. Etophylline plus Theophylline | Inj. Etophylline plus Theophylline | 50 | ampoules or vials | cmomgh | 45 | |
| 31 | Inj. Aspart Insulin | Inj. Aspart Insulin | 10 | ampoules or vials | cmomgh | 45 | |
| 32 | Inj. Iron Sucrose | Inj. Iron Sucrose | 2,000 | ampoules or vials | cmomgh | 45 | |
| 33 | Inj. Ethamsylate | Inj. Ethamsylate | 50 | ampoules or vials | cmomgh | 45 | |
| 34 | Inj. Human Actrapid -Regular Insulin | Inj. Human Actrapid -Regular Insulin | 20 | ampoules or vials | cmomgh | 45 | |
| 35 | Inj. Heparin | Inj. Heparin | 10 | ampoules or vials | cmomgh | 45 | |
| 36 | Inj. Ondansetron | Inj. Ondansetron | 25,000 | ampoules or vials | cmomgh | 45 | |
| 37 | Inj. Ranitidine | Inj. Ranitidine | 10,000 | ampoules or vials | cmomgh | 45 | |
| 38 | Inj. Dexamethasone | Inj. Dexamethasone | 1,000 | ampoules or vials | cmomgh | 45 |
Discover companies most likely to bid on this tender
Key insights about DELHI tender market
Bidders must meet turnover, provide audited financials, GST, PAN, and experience certificates; submit EMD of ₹40,700 via DD to Commissioner MCD, with hard copy within 5 days; include OEM authorizations and technical compliance documents per ATC.
Submit GST certificate, PAN card, audited financial statements or CA certificate for turnover, experience certificates for similar supply, EMD proof (DD), technical bid documents, OEM authorizations, and any mandatory certificates listed in ATC or Corrigendum.
Delivery must be to Mata Gujri Hospital, Tilak Nagar, New Delhi; on-site delivery and commissioning where applicable; quantity may vary up to 25% with extended delivery timelines calculated from original period, minimum 30 days.
The list includes glycopyrrolate, neostigmine, phenobarbitone, sodium bicarbonate infusion, phenytoin, potassium chloride, diltiazem, diazepam, levetiracetam, lorazepam, lidocaine, multivitamin infusions, nitroglycerine, prochlorperazine, triamcinolone, mitomycin, atropine, clonidine, ketamine, lignocaine formulations, saline 3%, tetanus toxoid, etophylline/theophylline, insulin, iron sucrose, etamsylate, heparin, ondansetron, ranitidine, and dexamethasone.
EMD is ₹40,700; turnover must be demonstrated for last 3 financial years via audited statements or CA certificate; non-new entities must show ongoing operations to meet average turnover criteria stated in the bid document.
The purchaser may increase ordered quantity up to 25% during contract; additional delivery time is calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum 30 days extension.
Bidders must provide OEM authorization where applicable, along with standard pharmaceutical documentation; failure to supply mandatory certificates per ATC can lead to rejection of the bid.
While the EMD can be submitted digitally, a hard-copy DD or proof must reach the buyer within 5 days after the bid end/opening date at the specified New Delhi address.